Caliper Posts Lighter Q2 Revenues Amid Fallen R&D Costs, Narrowed Loss | GenomeWeb

NEW YORK, July 31 - Caliper Technologies today reported a falloff in total revenue amid decreased R&D spending and a narrowed net loss.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.